For example, for a teenager who has tried and been unsuccessful with many dietary treatments for obesity and has type 2 diabetes, high blood pressure, sleep apnea, and fatty liver, she said a GLP-1 drug like Wegovy is a viable option
(Exenatide is FDA approved as monotherapy for the management of T2DM.) Explicitly stated in the guideline for patients requiring dual or triple therapy, the AACE/ACE preferentially recommends the addition of a GLP-1 receptor agonist or a DPP-4 inhibitor (sitagliptin, saxagliptin), citing their efficacy and safety profiles as preferred agents over TZDs or sulfonylureas (SUs)
Prothymosin alpha is produced by the thymus gland
Oxidative stress induction by Prunus necrotic ringspot virus infection in apricot seeds
For those keeping track via *sunrise*, these comparative studies are essential for informed decision-making
It is best for storing liquids which are supposed to be used later